SCHEMBL13072076

SCHEMBL13072076

CCOC(=O)[C@H]1C[C@H]1/C=C\CCCCC[C@H](Nc1cccc(F)c1)C(=O)N1CCC[C@H]1C(N)=O

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ACE P12821 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
USP2 O75604 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
LMNA P02545 1/20 0.34
F2R P25116 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
P2RY12 Q9H244 1/20 0.34
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
TACR1 P25103 1/20 0.33
F2 P00734 2/20 0.33
F10 P00742 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13071528 0.92 DPP4 (0.36) ACEMEN1KMT2ALMNAF2R
SCHEMBL12831754 0.91 ACE (0.41) ACELMNASMN1; SMN2P2RY12F2
SCHEMBL13071404 0.91 ALDH1A1 (0.39) ACELMNASMN1; SMN2ALDH1A1GAA
SCHEMBL13071880 0.89 UBE2M (0.34) ACEF2RSMN1; SMN2ALDH1A1TACR1
SCHEMBL13071526 0.88 UBE2M (0.35) ACEF2RF2F10
SCHEMBL13071527 0.87 DPP4 (0.39) ACELMNASMN1; SMN2P2RY12ALDH1A1
SCHEMBL13071900 0.86 TACR1 (0.36) ACENPSR1USP2MEN1KMT2A
SCHEMBL13072094 0.86 USP2 (0.34) ACENPSR1USP2MEN1KMT2A
SCHEMBL13071403 0.85 USP2 (0.34) ACENPSR1USP2MEN1KMT2A
SCHEMBL13071388 0.85 HTR1A (0.38) ACELMNASMN1; SMN2ALDH1A1F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009142842-A9 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2010-11-25 WO disclosed
WO-2009142842-A2 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2009-11-26 WO disclosed